Tiragolumab, Atezolizumab and Chemotherapy in Triple Negative Breast Cancer
Clinical trial NCT06175390 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06175390
- Sponsor
- Institut Curie
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-27
- Primary completion
- 2026-08-15
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.